[{"NetIncomeLossConverted_3_Q3_USD":12400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":137500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":136500000.0,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.23,"CommonStockSharesConverted_0_Q3_shares":136500000.0,"Assets_0_Q3_USD":11576000000.0,"RevenuesConverted_3_Q3_USD":3773800000.0,"RevenuesConverted_1_Q3_USD":1213700000.0,"StockholdersEquity_0_Q3_USD":5820300000.0,"EarningsPerShareDiluted_3_Q3_USD":0.09,"EarningsPerShareDiluted_1_Q3_USD":-1.13,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":525800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":136300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":136500000.0,"StockholdersEquityConverted_0_Q3_USD":5820400000.0,"NetIncomeLossConverted_1_Q3_USD":-154600000.0,"EarningsPerShareBasic_1_Q3_USD":-1.13,"EarningsPerShareBasic_3_Q3_USD":0.09,"Ticker":"PRGO","CIK":"1585364","name":"PERRIGO CO PLC","OfficialName":"Perrigo Company plc Ordinary Shares","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"4754722726.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20201105"}]